PHIO
Phio Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
PHIO fundamentals
Phio Pharmaceuticals (PHIO) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.45 (YoY +87.57%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.45
+87.57%
Report date
Aug 14, 2025
EPS
Actual | -143.64 | -36.72 | -43.2 | 16.2 | -34.56 | -21.6 | -30.24 | -27 | -20.52 | -20.52 | -28.08 | -21.78 | -28.35 | -13.23 | -10.26 | 5.04 | -4.23 | -3.62 | -1.54 | 0.31 | -0.41 | -0.45 | |||||||||||
Forecast | -69.66 | -40.5 | -45.36 | -28.08 | -27 | -34.56 | -32.4 | -33.48 | 38.88 | -29.16 | -12.87 | -11.7 | -4.59 | -4.14 | -1.23 | -0.36 | |||||||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +47.29% | -6.67% | +135.71% | 0.00% | +23.08% | -12.00% | +21.88% | +36.67% | +38.71% | -172.22% | +25.31% | 0.00% | 0.00% | +20.28% | +143.08% | 0.00% | +21.13% | +62.80% | +125.20% | 0.00% | -25.00% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | -- | -- | -- | -- | -- | -- | 12.50M | 37.50M | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is the market's earnings forecast for Phio Pharmaceuticals next quarter?What were the key takeaways from Phio Pharmaceuticals's earnings call?What is Phio Pharmaceuticals's latest dividend and current dividend yield?What guidance did Phio Pharmaceuticals's management provide for the next earnings period?What is the revenue and EPS growth rate for Phio Pharmaceuticals year over year?What factors drove the changes in Phio Pharmaceuticals's revenue and profit?Did Phio Pharmaceuticals beat or miss consensus estimates last quarter?What does Phio Pharmaceuticals do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
